Xylometazoline

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID2767
Ligand NameXylometazoline
PubMed Compound Id5709
StructureProduct Image
Molecular FormulaC16H24N2
Molecular Weight244.37
SMILESCC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C
Synonymsxylometazoline
526-36-3
Xylomethazoline
Otriven
Xilometazolina
2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole
Xylometazolinum
Balminil
WPY40FTH8K
2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline
1H-Imidazole, 2-((4-(1,1-dimethylethyl)-2,6-dimethylphenyl)methyl)-4,5-dihydro-
DTXSID8046957
1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-
stas
Nasan
Otrivin Mentol
Nasentropfen AL
Nasenspray AL
2-((4-tert-butyl-2,6-dimethylphenyl)methyl)-4,5-dihydro-1H-imidazole
NasenSpray ratiopharm
NasenTropfen ratiopharm
RefChem:58081
DTXCID6026957
2-(4'-tert-butyl-2',6'-dimethylphenylmethyl)imidazoline
R01AA07
R01AB06
S01GA03
208-390-6
Otrivin
Otrix
2-(4-(tert-butyl)-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole
Ba-11391
2-(4-tert-Butyl-2,6-dimethyl-benzyl)-4,5-dihydro-1H-imidazole
CHEMBL312448
2-IMIDAZOLINE, 2-(4-tert-BUTYL-2,6-DIMETHYLBENZYL)-
Ba 11391; Otriven; Otrivin
CHEBI:10082
Xylometazoline (INN)
XYLOMETAZOLINE [INN]
F1371-0282
2-{[4-(tert-butyl)-2,6-dimethylphenyl]methyl}-2-imidazoline
Xylometazoline [INN:BAN]
Xylometazolinum [INN-Latin]
Xilometazolina [INN-Spanish]
NCGC00016101-02
EINECS 208-390-6
UNII-WPY40FTH8K
Ba 11391
CAS-1218-35-5
BRN 0180524
Balminil (TN)
Spectrum_000382
Prestwick0_000223
Prestwick1_000223
Prestwick2_000223
Prestwick3_000223
Spectrum2_000945
Spectrum3_000586
Spectrum4_000382
Spectrum5_001469
Lopac-X-6000
XYLOMETAZOLINE [MI]
Lopac0_001269
SCHEMBL34087
BSPBio_000265
BSPBio_002032
GTPL517
KBioGR_000903
KBioSS_000862
5-23-07-00109 (Beilstein Handbook Reference)
DivK1c_000158
XYLOMETAZOLINE [VANDF]
SPBio_000910
SPBio_002186
BPBio1_000293
XYLOMETAZOLINE [WHO-DD]
BDBM30703
cid_5282386
HY-B0475A
KBio1_000158
KBio2_000862
KBio2_003430
KBio2_005998
KBio3_001532
NINDS_000158
HMS3604M22
HMS5085B13
SMSSF-0040298
2-(4-tert-Butyl-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole
MFCD00242956
s5854
SBB038185
STK558658
2-[(4-tert-butyl-2,6-dimethyl-phenyl)methyl]-4,5-dihydro-1H-imidazole
AKOS000115430
CCG-205342
DB06694
KS-5071
SDCCGSBI-0051235.P004
2-[[4-(1,1-Dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-1H-imidazole
IDI1_000158
C4X-17232Oxymetazoline EP Impurity B
NCGC00016101-01
NCGC00016101-03
NCGC00016101-04
NCGC00016101-05
NCGC00016101-06
NCGC00016101-07
NCGC00016101-09
NCGC00016101-18
NCGC00024281-03
ST024781
SBI-0051235.P003
DB-052151
CS-0013861
NS00000479
EN300-02385
VU0239751-6
C07913
D08684
G78137
Q31030
AB00053567_11
AB00053567_12
526B363
L001171
2-[(4-tert-butyl-2,6-xylyl)methyl]-2-imidazoline
BRD-K08356259-003-05-6
BRD-K08356259-003-15-5
BRD-K08356259-003-23-9
BRD-K08356259-003-24-7
2-(4-tert-butyl-2,6-dimethyl-benzyl)-2-imidazoline;hydrochloride
2-(4-tert-Butyl-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole #
2-[(4-t-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole
2-[(4-t-butyl-2,6-dimethylphenyl)methyl]4,5dihydro-1H-imidazole
2-[(4-tert-butyl-2,6-dimethyl-phenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochloride
2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochloride
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm